Linking cohorts, understanding biology, improving health

Search
Generic filters
Search News
News

EVENTS

IHCC Educational Webinar Series

Upcoming Webinar: 28 June 2022

Join Us Each Month

IHCC’s free educational webinar series features new speakers each month who present their research and expertise in various fields of health sciences. With the ultimate goal to bring cohorts together to enhance information-sharing and collaboration, this online series aims to provide a forum for cohort members to:

  • exchange scientific ideas, best practices, and lessons learned;
  • showcase cohorts’ accomplishments, emphasizing LMICs;
  • share international funding opportunities;
  • and more!

Upcoming Webinar

“Using the IHCC to Prevent Premature Death Around the Globe”

June 28, 2022, 8:00 AM EST, 12:00 PM UTC

Reza Malekzadeh M.D

Dr. Malekzadeh is a Professor at the Digestive Disease Research Institute of Tehran in Iran. He founded the institute in 2000 and has since expanded it further. His main field of interest is digestive oncology and chronic disease with a special interest in prevention of NCD. He has also supervised and conducted several epidemiological and clinical studies and even established the first large-scale cohort study in the Middle East and North Africa (Golestan Cohort Study).

Dr. Malekzadeh is currently a member of 20 large-scale international collaborative studies. Since cardiovascular diseases (CVD), cancers, and other chronic diseases are the leading causes of morbidity and mortality in Iran, he is interested in investigating the environmental and genetic risk factors of chronic diseases as well as metabolic syndrome. For this reason, he has since started the Pars (Southern Iran) and Golestan (Northern Iran) Cohort Studies and several other studies including clinical trials, case control and ecologic studies, collecting detailed data and biological samples from cohort subjects and patients with cancer, CVD, chronic liver disease especially HBV, NAFLD/NASH.

He’s also established a pragmatic randomized control trial of healthy life style and polypill for prevention of CVD and other NCD nested within the Golestan and pars cohort as well as the Persian Cohort, which includes all seven ethnicities of Iran with 200,000-sample size from 20 different provinces.

About the Talk

SDG of 30% reduction in premature mortality due to non-communicable diseases: The age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high-income countries. There is an urgent need to focus on implementing existing cost-effective policies and interventions if the world is to meet the targets for Sustainable Development Goal 3 and achieve a 30% reduction in premature mortality due to non-communicable diseases. The use of a polypill containing a statin, two BP-​lowering agents each at half-​standard dose, and aspirin (75 mg) given to everyone aged ≥50 years and everyone with existing CVD could result in a >50% reduction in cardiovascular events.

Apply To Be a Speaker

Interested in speaking at an upcoming webinar? Use the form below to provide us with some information on your proposed topic and your availability to speak. 

Previous Webinars

April 26, 2022: Terra and the Biomedical Data Ecosystem 
Presented by: Dr. Geraldine Van der Auwera

March 31, 2022: Genomic Data Sharing for Global Health
Presented by: Peter Goodhand

February 28, 2022: Diversity in Africa or Novel COVID Host Susceptibility Study
Presented by: Dr. Michèle Ramsay and Dr. Andrew May

VIEW 2021 WEBINARS

We Want to Hear From You!

For questions or feedback regarding the IHCC Educational Webinar Series, or to suggest a speaker for a future meeting, please contact us at ihccinfo@ihccglobal.org